MASI
Masimo Corporation
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
Masimo (MASI) Stock: Buy, Sell, or Hold?
$179.95
+0.01 (+0.01%)
â˛
5d:
+0.68%
30d:
+0.92%
90d:
+2.54%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
53/100
Position
FAIR
Forward P/E & Valuation
27.3x
FAIR
vs 26.3x historical avg
Wall Street Target
$180.00
Consensus price target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$178.30 / $179.99
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MASI is fairly priced but lacks strong directional signals. At 1.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When MASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$236.63
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$146.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MASI is currently trading at $179.95, which is considered fair based on recent price action. The stock's valuation (Forward PE: 27.3) is in line with its historical norms (26.3). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $178.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $178.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
53/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.8%
Trading Range & Key Levels
Support Level
$178.30
Resistance Level
$179.99
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- NEUTRAL: Near Wall St target ($180.00)
- NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
27.26
Wall Street Target
$180.00
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
214.4%
Profit Margin
4.9%
Valuation Premium vs History
+1.2% premium
PE vs Historical
27.3 vs 26.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.2%
(market-implied from PE analysis)
1-Year Target
$182.11
(+1%)
2-Year Target
$184.29
(+2%)
3-Year Target
$186.51
(+4%)
3-Yr Target (if PE normalizes)
(PE: 27â26)
PE COMPRESSION
$179.95
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.3, Growth: 11.0%)
$245.79
(+37%)
Base:
(SPY PE: 21.9, Growth: 11.0%)
$197.66
(+10%)
Bear:
(PE: 18.6, Growth: 11.0%)
$168.01
(-7%)
Share MASI Analysis
Share this live MASI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MASI)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Feb 17, 2026
Daily AI digest
AI Retail Discussion Summary:
Masimo's stock price surged following news of Danaher's $9.9 billion acquisition offer. Traders expressed bullish sentiment on StockTwits.
Key Retail Themes:
Masimo acquisition
Bullish trader sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:53 AM ET
Data refreshes hourly during market hours. Next update: 5:53 AM
Data refreshes hourly during market hours. Next update: 5:53 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MASI Research Pages
